Solid Biosciences Inc. Balance Sheet
SLDB|5 years of annual SEC 10-K data (FY2018-FY2022)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 5 fiscal years. All figures from audited SEC 10-K filings.
Solid Biosciences Inc. had $260M in total assets and $208M in shareholders' equity as of FY2022.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Cash & Equivalents | $119.1M | $76.0M | $86.4M | $86.4M | $52.1M |
| Current Assets | $219.6M | $222.6M | $158.9M | $86.3M | $128.6M |
| PP&E (Net) | $9.7M | $6.5M | $8.2M | $11.6M | $10.4M |
| Total Assets | $260.3M | $232.4M | $171.2M | $103.5M | $139.6M |
| Current Liabilities | $22.5M | $23.6M | $24.5M | $18.3M | $12.5M |
| Shareholders' Equity | $208.2M | $132.1M | $80.0M | $125.2M | -$59.3M |